 |
A special article following the relicence of aprotinin injection in Europe
David Royston 1
Author
Stefan de Hert 2
Author
Jan van der Linden 3
Author
Alexandre Ouattara 4, 5
Author
Kai Zacharowski 6
Author
1
Royal Brompton and Harefield NHS Foundation Trust (United Kingdom)
2
Ghent University Hospital (De Pintelaan 185, 9000 Gent, Belgium - Belgium)
3
Karolinska Institutet [Stockholm] (Solnavägen 1, 171 77 Solna
Stockholm - Sweden)
4
Service Anesthésie - Réanimation [Bordeaux] (Place Amélie Raba-Léon
33000 Bordeaux - France)
- CHU Bordeaux [Bordeaux] (place Amélie Raba Léon 33076 BORDEAUX CEDEX - France)
5
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases (1 avenus Magellan, 33600 Pessac - France)
- UB - Université de Bordeaux (35, place Pey Berland - 33076 Bordeaux - France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : U1034 (101, rue de Tolbiac, 75013 Paris - France)
- CNRS - Centre National de la Recherche Scientifique (France)
6
Universitätsklinikum Frankfurt (Theodor-Stern-Kai 7
60590 Frankfurt - Germany)
Document type :
Journal articles
Complete list of metadatas
https://www.hal.inserm.fr/inserm-02469573
Contributor : Christelle Boullé <>
Submitted on : Thursday, February 6, 2020 - 4:03:35 PM
Last modification on : Thursday, February 13, 2020 - 1:35:11 AM
Contributor : Christelle Boullé <>
Submitted on : Thursday, February 6, 2020 - 4:03:35 PM
Last modification on : Thursday, February 13, 2020 - 1:35:11 AM
Identifiers
- HAL Id : inserm-02469573, version 1
- DOI : 10.1016/j.accpm.2017.02.001
- PUBMED : 28215980
Collections
Citation
David Royston, Stefan de Hert, Jan van der Linden, Alexandre Ouattara, Kai Zacharowski. A special article following the relicence of aprotinin injection in Europe. Anaesthesia Critical Care & Pain Medicine, Elsevier Masson, 2017, 36 (2), pp.97-102. ⟨10.1016/j.accpm.2017.02.001⟩. ⟨inserm-02469573⟩
Metrics
Record views
